Navigation Links
Linkwell Corporation Announces Launch of the 'Series of Handwashing Contest' Across China
Date:8/25/2009

SHANGHAI, Aug. 25 /PRNewswire-Asia/ -- Linkwell Corporation (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, announced that its 90% held subsidiary, Shanghai Likang Hi-Tech Co., Ltd, will launch a series of campaigns, entitled "The Shield of Likang -- The National Contest of Hand-washing" across the country for one year, from September 2009 to September 2010.

The COO of Linkwell, Mr. Chunming Huang said, "Hand washing is playing a more and more important role in preventing the spread of all kinds of diseases worldwide, like the SARS and H1N1 viruses, among others. Furthermore, the increasing numbers of disastrous incidents of nosocomial infection in China recent years, such as at the First Affiliated Hospital of Xi'an, Jiaotong University School of Medicine and TianJin Jixian County Maternal and Child Care Service Center, all show that there is still a very long way to go for hospital infection control and management in China. According to an authoritative report from the World Health Organization, proper hand washing can decrease hospital infections by nearly 60%. Medical institutions in China are still far behind their peers in other countries both in awareness and facilities in terms of hand disinfection.

"To fully explore the hand disinfectant market, integrating advanced western ideas and the Chinese national condition, the Likang company has put out the Jifro(R), Putai(TM) series of hand disinfectant products, with 6 series and more than 40 specifications, covering all sectors from hand washing, hand disinfection and surgical hand disinfection. Likang owns most hand disinfectants approved by the Chinese Health Ministry at present," said Mr Huang.

"We will work with professional associations from the Chinese nosocomial committee to carry on this contest nationwide, as well as develop various symposiums regarding the relationship between hand disinfection and infection control, through which we can do some material work to help highlight the awareness of hand hygiene and improve hand washing and disinfection standards around the country." Mr Huang also mentioned, "At the same time the company has selected hand disinfectant as a New Profit-increasing Point for the rest of this year. It is planed that the sales of hand disinfectant will increase 15 million RMB this year, rising nearly 50% compared to last year, and the hand disinfectant sector should account for 30% of the total revenues of the whole company other than the 18% in the year of 2008.

"Likang is in possession of more than ten patents in this field and its products have been very close to those of multi-national corporations both in design and quality, and are even more excellent in some aspects. While other domestic competitors are still behind us, we have faith that this campaign, though our make great effort, will be very successful," Mr. Huang concluded.

About Linkwell Corporation

Linkwell Corporation, through its 90% ownership of its subsidiary, Linkwell Tech Group, Inc., develops, manufactures and distributes disinfectant healthcare products in China. Linkwell's disinfectant healthcare products are recognized as one of leading domestic Chinese brands in this market segment. Linkwell currently has 56 different products including disinfectants in liquid, tablet, powder and aerosol forms. Linkwell has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of China. For more information, please visit http://www.linkwell.us .

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the Company's operations, financial performance and condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The Company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, but not limited to, the impact of competitive products; pricing and new technology; changes in consumer preferences and tastes; effectiveness of marketing; changes in laws and regulations; fluctuations in costs of production; and other factors as those discussed in the Company's reports filed with the Securities and Exchange Commission from time to time. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.


'/>"/>
SOURCE Linkwell Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
2. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
3. Shanghai Disinfection Association and Linkwell Corporation Co-Establish the Shanghai Disinfection Association Laboratory Center
4. Linkwell Corp to File to Extend Filing Date for 2007 Form 10-K
5. Linkwell Corporation Year-End 2007 Earnings Release and Conference Call Notice
6. Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics
7. Linkwell Corporation Begins Training and Licensing Beijing Olympics Disinfection Teams
8. Linkwell Corporation Runs 24/7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts
9. Linkwell Corporation Disinfection Epidemic Prevention Teams Enter into Sichuan Earthquake Area
10. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the ... in an average life. This mouse sets out on a journey that will show ... Mouseson” is the creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is ... of mind and move the readers one step closer to God. “Psalms of Humidity” ... that his mistakes that have been made within his life are the very same ...
(Date:9/20/2017)... ... ... Sang At Her Funeral”: a tale of murder that will bring a church together ... Sang At Her Funeral” is the creation of published author, Annalise Harold, an IT ... twelve grandchildren. Before becoming a writer, Annalise had the opportunity to relocate often while ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were ... Brevard’s own Ross A. Clevens, MD, FACS . The founder and medical director ... and Reconstructive Surgeon who trained at Yale, Harvard and the University of Michigan. He ...
(Date:9/19/2017)... ... 19, 2017 , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two important ... excess of $835 million in resolved debt for its clients. , Credit card debt, ... the categories of debt settled by the company. With more than a decade of ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
(Date:8/29/2017)... 2017 ivWatch, LLC, the leading provider of continuous monitoring ... has been awarded an Innovative Technology contract from Vizient, Inc., the ... ... in the early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ...
Breaking Medicine Technology: